Healthcare and Life Science
Scottish Brain Sciences opens new Alzheimer’s clinical research centre at ONE BioHub
Aberdeen clinical research centre widens access to clinical trials across Scotland, advancing early Alzheimer’s researchONE BioHub provides Scottish Brain Sciences with infrastructure and integrated support to scale operations and drive forward its pioneering neurological researchEdinbu...
Mosaic Therapeutics appoints Dr Stephen Shuttleworth as Chief Scientific Officer
Venture Partner at Samsara BioCapital, and former CSO and COO of Karus Therapeutics, brings deep scientific and industry experience to Mosaic’s Executive Leadership teamStephen will lead the Company’s scientific strategy, preclinical pipeline build and R&D organisationCambridge, UK,...
Trust emergency doctor wins second prestigious honour
An Addenbrooke’s doctor dedicated to shaping front line emergency care in the East of England – and influencing it worldwide - has won a second coveted award for his work. ...
Mystery of treatment-resistant childhood leukaemia uncovered
A new type of cancer cell that “warrants urgent investigation” has been discovered in childhood leukaemia, and could impact clinical care. Research into new or repurposed treatments that target this new cell type could give hope to children and families worldwide. ...
Sanger scientists receive major grant to study rise of early onset colorectal cancer
Wellcome Sanger Institute researchers, Professor Sir Mike Stratton and Dr Trevor Lawley, together with Dr Paul Brennan of the International Agency for Research on Cancer (IARC) have been awarded a significant grant, enabling their team to investigate the causes of early onset colorectal...
Arecor enhances IP coverage for AT278 and Oral Delivery Technology
Cambridge, UK - Arecor Therapeutics plc, the biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic diseases, provides an update on the broadening of its IP position. ...
145 families receive a diagnosis with new genomic method
Experts have developed a new method for identifying structural changes in DNA, providing insights for 145 families and highlighting the importance of incorporating these changes into clinical practice. ...
How clinics can optimise patient pathways in early pregnancy care
In early pregnancy, time isn’t a luxury patients have. Clinical decisions depend on precise diagnostic information that will guide treatment, intervention, and reassurance for patients. However, many services still experience what can be termed ‘decision delay’: a critical lag between t...
Mursla Bio collaborates with a leading global pharma company to advance biomarker-guided precision medicine in MASH
Mursla Bio’s AI Precision Medicine Platform to inform drug development and patient stratification in metabolic liver diseaseCambridge, UK, and Boston MA, USA, 13 November 2025: Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and s...
Abselion launches His-tagged Protein Quantification Kit and Sensors for Amperia at PEGS Europe 2025
Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged proteins Broadens Amperia’s applications across recombinant protein research, screening, and developmentAbselion to showcase kit alongside Amperia platform at PEGS Eu...